Telik Inc (NASDAQ:TELK)
CAPS Rating:
A biopharmaceutical company working to discover, develop and commercialize innovative small molecule drugs to treat diseases.
Growing the love for investing
A biopharmaceutical company working to discover, develop and commercialize innovative small molecule drugs to treat diseases.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
Gotta love those pharma wannabes. Phase III trials a bust, no profitability, spend the money on lottery tickets--less risk. Come on TELIK, improve my score ;->.